Hennion & Walsh Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$6.45M	Sell
2022 Q2	$6.48M	Sell
2022 Q1	$10M	Sell
2021 Q4	$12M	Sell
2021 Q3	$15.9M	Buy
2021 Q2	$11M	Buy
2021 Q1	$6.66M	Buy